Trials / Completed
CompletedNCT05648435
Lithium Clearance in Patients With High Risk of Acute Kidney Injury
Proximal Tubule Function in Septic Patients as Measured by Endogenous Lithium Clearance
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 21 (actual)
- Sponsor
- University Hospital of North Norway · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
Renal lithium clearance is hypothesized to be a useful indicator of renal tubular function. In this study lithium clearance will be monitored in patients with sepsis associated acute kidney injury and in healthy controls.
Detailed description
Lithium is almost completely reabsorbed in the proximal tubule in parallel with sodium and water. What is not reabsorbed here is assumed to be fully excreted in urine, giving a reasonably accurate measurement of sodium reabsorption in the proximal tubule. Endogenous lithium clearance will be measured by inductively coupled plasma mass spectrometry (ICP-MS). The Gomez equations will be applied to calculate efferent arteriolar resistance, afferent arteriolar resistance, glomerular hydrostatic pressure, glomerular filtration pressure, and glomerular oncotic pressure. N-acetyl-β-D glucosaminidase (NAG) and NGAL, markers of tubular injury, will be measured by a spectrophotometric method using a commercially available kit. Routine blood and urine analyses will be performed at the Diagnostic Clinic Laboratory, University Hospital of North Norway, Tromsø.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Lithium measures | Measurements of lithium levels in blood and urine |
Timeline
- Start date
- 2022-12-07
- Primary completion
- 2023-01-31
- Completion
- 2023-01-31
- First posted
- 2022-12-13
- Last updated
- 2023-04-12
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT05648435. Inclusion in this directory is not an endorsement.